메뉴 건너뛰기




Volumn 5, Issue 2, 1998, Pages 206-207

Management of neonatal buprenorphine withdrawal with paregoric [2];Buprenorphine (Subutex®) et syndrome de sevrage neonatal

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; PAREGORIC; ANTIDIARRHEAL AGENT; NARCOTIC ANALGESIC AGENT; OPIATE;

EID: 0031988004     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)86842-X     Document Type: Article
Times cited : (11)

References (7)
  • 5
    • 0029008839 scopus 로고
    • Syndrome de sevrage chez un nouveau-né de mère toxicomane recevant de la méthadone
    • 5 Baglin S, Avenel S, Renaud C, Bavoux F, Francoual C, Badoual J. Syndrome de sevrage chez un nouveau-né de mère toxicomane recevant de la méthadone. Arch Pédiatr 1995 ; 2 : 702-3
    • (1995) Arch Pédiatr , vol.2 , pp. 702-703
    • Baglin, S.1    Avenel, S.2    Renaud, C.3    Bavoux, F.4    Francoual, C.5    Badoual, J.6
  • 6
    • 0000226802 scopus 로고
    • Absorption, distribution, metabolism and excretion of buprenorphine in animals and humans
    • New York: Wiley-Liss, Inc
    • 6 Walters DS, Inturrisi CE. Absorption, distribution, metabolism and excretion of buprenorphine in animals and humans. In: Buprenorphine: combatting drug abuse with a unique opoid. New York: Wiley-Liss, Inc; 1995. p 113-35
    • (1995) Buprenorphine: Combatting Drug Abuse with A Unique Opoid , pp. 113-135
    • Walters, D.S.1    Inturrisi, C.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.